Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
43
PharmaCompass offers a list of Momelotinib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Momelotinib Hydrochloride manufacturer or Momelotinib Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Momelotinib Hydrochloride manufacturer or Momelotinib Hydrochloride supplier.
A Momelotinib dihydrochloride monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Momelotinib dihydrochloride monohydrate, including repackagers and relabelers. The FDA regulates Momelotinib dihydrochloride monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Momelotinib dihydrochloride monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Momelotinib dihydrochloride monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Momelotinib dihydrochloride monohydrate supplier is an individual or a company that provides Momelotinib dihydrochloride monohydrate active pharmaceutical ingredient (API) or Momelotinib dihydrochloride monohydrate finished formulations upon request. The Momelotinib dihydrochloride monohydrate suppliers may include Momelotinib dihydrochloride monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Momelotinib dihydrochloride monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Momelotinib dihydrochloride monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Momelotinib dihydrochloride monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Momelotinib dihydrochloride monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Momelotinib dihydrochloride monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Momelotinib dihydrochloride monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Momelotinib dihydrochloride monohydrate suppliers with NDC on PharmaCompass.
Momelotinib dihydrochloride monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Momelotinib dihydrochloride monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Momelotinib dihydrochloride monohydrate GMP manufacturer or Momelotinib dihydrochloride monohydrate GMP API supplier for your needs.
A Momelotinib dihydrochloride monohydrate CoA (Certificate of Analysis) is a formal document that attests to Momelotinib dihydrochloride monohydrate's compliance with Momelotinib dihydrochloride monohydrate specifications and serves as a tool for batch-level quality control.
Momelotinib dihydrochloride monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Momelotinib dihydrochloride monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Momelotinib dihydrochloride monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Momelotinib dihydrochloride monohydrate EP), Momelotinib dihydrochloride monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Momelotinib dihydrochloride monohydrate USP).
